Denis Coleman, MSME, MSMS, PhD
Dr. Coleman cofounded Symantec, a world leader in information security and the maker of Norton antivirus software. Today Symantec is a Fortune 500 company with over 18,000 employees and more than $6 billion in annual revenue. Dr. Coleman has helped start 14 companies in such diverse fields as optical character recognition, targeted Internet advertising, social networking software, and, most recently, biotechnology. One of his most well-known, game-changing inventions was the development of the first spell checker for a microcomputer, originally marketed in 1980 through a company called Innovative Software. He has served variously as early board member, founder, software designer/developer in 11 other startups, three of which had IPOs, including Neoforma, an online medical supply and equipment marketplace, Visioneer a hardware/software office imaging solutions, now merged with Nuance, and Financial Engines. Dr. Coleman earned his undergraduate degree and two Masters degrees from the Massachusetts Institute of Technology, and a PhD from Stanford University.
Mr. Melohn spent the last 25 years immersed in the Internet and the world of distributed systems. He most recently served as Vice President, Chief Technology Officer of Network Systems at Cisco Systems where his team produced over 200 patents, including work in applied cryptography, network address translation, quality of service, keying infrastructure, secure tunneling and configuration, and many other areas. Mr. Melohn and his team were twice winners of Cisco’s Pioneer Technology Award and was one of the top engineering teams to bring innovation to Cisco’s product line. Prior to joining Cisco, Mr. Melohn was at Sun Microsystems, where he created the Internet Engineering Group. He has co-authored several Internet RFCs, including Requirements for Internet Hosts and the Point-to-Point Protocol. He was director of Software Engineering at file server maker Auspex Systems, and the director of network engineering at Silicon Graphics where he and his team designed the world’s fastest TCP/IP-based network equipment, file servers, and web server platforms. At FlowWise Networks, Mr. Melohn was VP of Engineering where he led the team that designed a routing accelerator that won numerous industry awards. Mr. Melohn earned his undergraduate degree from the University of Southern California.
Michael Sailor, MS, PhD
Dr. Sailor is a Professor of Chemistry and Biochemistry and the Leslie Orgel Scholar in Inorganic Chemistry at the University of California, San Diego with affiliate appointments in the Department of Bioengineering and the Department of Nanoengineering. He is on the executive steering committee for UCSD’s Materials Science PhD Program and a member of the Moores Cancer Center at UCSD. Dr. Sailor is widely regarded as one of the leading global authorities on porous silicon. He has authored over 200 research publications in subjects related to nanotechnology, biomaterials, chemistry, sensors and electrochemistry, and is a named inventor on over 25 issued or pending patents. Dr. Sailor is on the editorial advisory board of the journals Advanced Materials, Advanced Healthcare Materials, ACS Nano, and Chemical Communications. He also has served on the United States Air Force Scientific Advisory Board, for which he earned the US Air Force’s Award for Meritorious Civilian Service. Dr. Sailor earned his undergraduate degree from Harvey Mudd College and a Masters and PhD from Northwestern University.
Jesse Wu, MBA
Mr. Wu is a global business executive with extensive multinational business management experience. He currently serves as Non-Executive Director of The a2 Milk Company, an Australia/New Zealand-listed dairy nutrition company; Li Ning Company, a Hong Kong-listed Chinese sports brand company; and Kehua Bio-engineering Company, a China-listed laboratory instruments and reagents company. In 2016, Mr. Wu retired from Johnson & Johnson where he served as Chairman of Johnson & Johnson China and a member of the Johnson & Johnson Management Committee. He was previously Worldwide Chairman of Johnson & Johnson’s Consumer Group, managing a US$14 billion portfolio of consumer healthcare brands. Mr. Wu is a member of the Board of Visitors at Duke University’s Fuqua School of Business. He also serves on the advisory boards of Duke Kunshan University and the Center for Talented Youth at John Hopkins University. Jesse was a two-time recipient of the Magnolia Award, an honor conferred by the Shanghai government for his contributions to the city’s economic development. Mr. Wu received an undergraduate degree in Economics from National Chengchi University in Taiwan, and an MBA degree from Duke University’s Fuqua School of Business.
Jeffrey Yu, MD
Dr. Yu is the Chief Technology Officer for The Queen’s Health System, one of the largest healthcare systems in the State of Hawaii, where he oversees information and biomedical technology strategy. He is a board-certified diagnostic Radiologist and a fellowship-trained nuclear medicine physician, and has served as Chief of Radiology and CEO of the radiology group at The Queen’s Health System. Dr. Yu is also a serial entrepreneur–he is founder and CTO of OneMedNet, a medical imaging software company whose BEAM image sharing solution is sold by GE Healthcare and McKesson Health Solutions, and he is founder and CEO of KinetiCor, a leading motion correction technology company for medical imaging. Dr. Yu received a Bachelor’s degree in Neurobiology and Neurosciences from the University of California, Berkeley, a Medical Doctorate from Wake Forest University, and he completed his residency program in Diagnostic Radiology and fellowship in Nuclear Medicine at the Mallinckrodt Institute of Radiology at the Washington University Medical Center.